Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0332 Transporter Info | ||||
Gene Name | SLC38A5 | ||||
Transporter Name | Sodium-coupled neutral amino acid transporter 5 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg02151779) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.34E+00 | Statistic Test | p-value:1.20E-08; Z-score:-1.86E+00 | ||
Methylation in Case |
5.11E-01 (Median) | Methylation in Control | 6.85E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg14522327) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.26E+00 | Statistic Test | p-value:9.24E-07; Z-score:1.46E+00 | ||
Methylation in Case |
8.59E-01 (Median) | Methylation in Control | 6.82E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg17590101) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.36E+00 | Statistic Test | p-value:2.10E-06; Z-score:1.44E+00 | ||
Methylation in Case |
6.44E-01 (Median) | Methylation in Control | 4.73E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC38A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg19407886) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:2.98E-06; Z-score:1.19E+00 | ||
Methylation in Case |
8.75E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC38A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg20495737) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:4.22E-06; Z-score:1.16E+00 | ||
Methylation in Case |
8.90E-01 (Median) | Methylation in Control | 8.17E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC38A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg24152857) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.29E+00 | Statistic Test | p-value:8.01E-06; Z-score:1.25E+00 | ||
Methylation in Case |
7.99E-01 (Median) | Methylation in Control | 6.20E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC38A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg04700811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.48E+00 | Statistic Test | p-value:3.19E-14; Z-score:-2.13E+00 | ||
Methylation in Case |
4.24E-01 (Median) | Methylation in Control | 6.27E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC38A5 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg23948362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.20E+00 | Statistic Test | p-value:1.20E-09; Z-score:-1.96E+00 | ||
Methylation in Case |
7.36E-01 (Median) | Methylation in Control | 8.84E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A5 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg19407886) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.59E+00 | Statistic Test | p-value:3.86E-12; Z-score:-1.75E+01 | ||
Methylation in Case |
3.25E-01 (Median) | Methylation in Control | 5.16E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A5 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg18492059) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-2.16E+00 | Statistic Test | p-value:8.37E-09; Z-score:-8.60E+00 | ||
Methylation in Case |
3.04E-01 (Median) | Methylation in Control | 6.56E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A5 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg26735834) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.49E+00 | Statistic Test | p-value:4.02E-06; Z-score:-4.28E+00 | ||
Methylation in Case |
5.17E-01 (Median) | Methylation in Control | 7.68E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC38A5 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg03021892) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.31E+00 | Statistic Test | p-value:5.53E-06; Z-score:-4.15E+00 | ||
Methylation in Case |
6.01E-01 (Median) | Methylation in Control | 7.85E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC38A5 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg16536563) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.21E+00 | Statistic Test | p-value:5.35E-06; Z-score:-9.12E+00 | ||
Methylation in Case |
6.14E-01 (Median) | Methylation in Control | 7.40E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC38A5 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg21197919) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:6.58E-06; Z-score:-8.08E+00 | ||
Methylation in Case |
6.56E-01 (Median) | Methylation in Control | 8.06E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC38A5 in bladder cancer | [ 2 ] | |||
Location |
Body (cg24455325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.84E+00 | Statistic Test | p-value:5.72E-07; Z-score:-2.84E+01 | ||
Methylation in Case |
2.82E-01 (Median) | Methylation in Control | 5.19E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC38A5 in bladder cancer | [ 2 ] | |||
Location |
3'UTR (cg23948362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:1.35E-03; Z-score:-2.25E+00 | ||
Methylation in Case |
4.84E-01 (Median) | Methylation in Control | 6.07E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A5 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg19407886) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:4.22E-05; Z-score:-9.86E-01 | ||
Methylation in Case |
3.99E-01 (Median) | Methylation in Control | 4.28E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A5 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg14522327) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:6.13E-03; Z-score:6.41E-01 | ||
Methylation in Case |
4.14E-01 (Median) | Methylation in Control | 3.60E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A5 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg17590101) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:2.03E-02; Z-score:-7.40E-01 | ||
Methylation in Case |
6.91E-01 (Median) | Methylation in Control | 7.35E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC38A5 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg20495737) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.13E+00 | Statistic Test | p-value:4.69E-02; Z-score:-7.84E-01 | ||
Methylation in Case |
5.47E-01 (Median) | Methylation in Control | 6.19E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC38A5 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg26735834) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:3.15E-05; Z-score:-1.02E+00 | ||
Methylation in Case |
5.98E-01 (Median) | Methylation in Control | 6.52E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC38A5 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg18492059) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:3.51E-04; Z-score:-7.43E-01 | ||
Methylation in Case |
5.11E-01 (Median) | Methylation in Control | 5.55E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC38A5 in breast cancer | [ 3 ] | |||
Location |
3'UTR (cg23948362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:1.25E-02; Z-score:-9.14E-01 | ||
Methylation in Case |
5.59E-01 (Median) | Methylation in Control | 5.93E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
5'UTR (cg19407886) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:2.79E-07; Z-score:-1.47E+00 | ||
Methylation in Case |
4.33E-01 (Median) | Methylation in Control | 5.40E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
5'UTR (cg14522327) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.53E+00 | Statistic Test | p-value:1.28E-02; Z-score:4.42E-01 | ||
Methylation in Case |
1.53E-01 (Median) | Methylation in Control | 9.99E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
5'UTR (cg20495737) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.22E+00 | Statistic Test | p-value:2.65E-02; Z-score:9.14E-01 | ||
Methylation in Case |
4.89E-01 (Median) | Methylation in Control | 3.99E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC38A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg03021892) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.17E+00 | Statistic Test | p-value:5.04E-09; Z-score:-1.67E+00 | ||
Methylation in Case |
6.67E-01 (Median) | Methylation in Control | 7.84E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC38A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg18492059) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:2.29E-05; Z-score:-8.83E-01 | ||
Methylation in Case |
7.60E-01 (Median) | Methylation in Control | 8.04E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC38A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg26735834) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:1.93E-03; Z-score:-2.38E-01 | ||
Methylation in Case |
8.67E-01 (Median) | Methylation in Control | 8.75E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC38A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS200 (cg21197919) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.12E+00 | Statistic Test | p-value:4.49E-07; Z-score:-1.32E+00 | ||
Methylation in Case |
7.21E-01 (Median) | Methylation in Control | 8.08E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC38A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
TSS200 (cg16536563) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:5.90E-05; Z-score:-8.77E-01 | ||
Methylation in Case |
7.29E-01 (Median) | Methylation in Control | 8.13E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC38A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
Body (cg24455325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.18E+00 | Statistic Test | p-value:1.67E-08; Z-score:-1.90E+00 | ||
Methylation in Case |
5.91E-01 (Median) | Methylation in Control | 6.96E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC38A5 in hepatocellular carcinoma | [ 4 ] | |||
Location |
3'UTR (cg04700811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:8.62E-07; Z-score:-1.32E+00 | ||
Methylation in Case |
8.11E-01 (Median) | Methylation in Control | 8.44E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
5'UTR (cg20495737) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-3.89E+00 | Statistic Test | p-value:5.21E-04; Z-score:-1.92E+00 | ||
Methylation in Case |
1.25E-01 (Median) | Methylation in Control | 4.87E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
5'UTR (cg17590101) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-4.17E+00 | Statistic Test | p-value:6.18E-04; Z-score:-1.87E+00 | ||
Methylation in Case |
1.46E-01 (Median) | Methylation in Control | 6.09E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
5'UTR (cg14522327) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-5.82E+00 | Statistic Test | p-value:1.72E-03; Z-score:-1.58E+00 | ||
Methylation in Case |
6.13E-02 (Median) | Methylation in Control | 3.57E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
5'UTR (cg24152857) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-6.08E+00 | Statistic Test | p-value:2.28E-03; Z-score:-1.63E+00 | ||
Methylation in Case |
5.20E-02 (Median) | Methylation in Control | 3.16E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
5'UTR (cg02151779) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-4.87E+00 | Statistic Test | p-value:3.40E-03; Z-score:-1.65E+00 | ||
Methylation in Case |
4.26E-02 (Median) | Methylation in Control | 2.07E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
5'UTR (cg19407886) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:1.39E-02; Z-score:3.19E-01 | ||
Methylation in Case |
4.63E-01 (Median) | Methylation in Control | 4.51E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
TSS1500 (cg03021892) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:2.22E-04; Z-score:7.14E-01 | ||
Methylation in Case |
9.07E-01 (Median) | Methylation in Control | 8.67E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
TSS1500 (cg18492059) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:1.85E-03; Z-score:1.01E+00 | ||
Methylation in Case |
8.68E-01 (Median) | Methylation in Control | 8.21E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
TSS1500 (cg26735834) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:8.96E-03; Z-score:6.95E-01 | ||
Methylation in Case |
9.00E-01 (Median) | Methylation in Control | 8.80E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
TSS200 (cg16536563) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:6.58E-06; Z-score:9.46E-01 | ||
Methylation in Case |
8.74E-01 (Median) | Methylation in Control | 7.91E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
TSS200 (cg21197919) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:4.07E-04; Z-score:7.88E-01 | ||
Methylation in Case |
8.82E-01 (Median) | Methylation in Control | 8.46E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
3'UTR (cg23948362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:1.68E-04; Z-score:1.12E+00 | ||
Methylation in Case |
9.12E-01 (Median) | Methylation in Control | 8.44E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC38A5 in HIV infection | [ 5 ] | |||
Location |
3'UTR (cg04700811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:2.50E-03; Z-score:1.05E+00 | ||
Methylation in Case |
9.38E-01 (Median) | Methylation in Control | 9.16E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A5 in systemic lupus erythematosus | [ 6 ] | |||
Location |
5'UTR (cg19407886) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:1.42E-04; Z-score:-3.23E-01 | ||
Methylation in Case |
5.00E-01 (Median) | Methylation in Control | 5.20E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A5 in systemic lupus erythematosus | [ 6 ] | |||
Location |
5'UTR (cg14522327) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.07E-02; Z-score:1.16E-01 | ||
Methylation in Case |
4.58E-01 (Median) | Methylation in Control | 4.40E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A5 in systemic lupus erythematosus | [ 6 ] | |||
Location |
5'UTR (cg24152857) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:2.50E-02; Z-score:8.83E-02 | ||
Methylation in Case |
3.68E-01 (Median) | Methylation in Control | 3.56E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC38A5 in systemic lupus erythematosus | [ 6 ] | |||
Location |
TSS1500 (cg03021892) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.45E-04; Z-score:-3.94E-01 | ||
Methylation in Case |
8.34E-01 (Median) | Methylation in Control | 8.51E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC38A5 in systemic lupus erythematosus | [ 6 ] | |||
Location |
TSS200 (cg16536563) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:1.62E-03; Z-score:-3.19E-01 | ||
Methylation in Case |
7.80E-01 (Median) | Methylation in Control | 7.98E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC38A5 in systemic lupus erythematosus | [ 6 ] | |||
Location |
Body (cg24455325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:4.79E-02; Z-score:-2.00E-01 | ||
Methylation in Case |
8.69E-01 (Median) | Methylation in Control | 8.77E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC38A5 in systemic lupus erythematosus | [ 6 ] | |||
Location |
3'UTR (cg23948362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:2.99E-03; Z-score:-3.06E-01 | ||
Methylation in Case |
8.13E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC38A5 in systemic lupus erythematosus | [ 6 ] | |||
Location |
3'UTR (cg04700811) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:5.24E-03; Z-score:-1.48E-01 | ||
Methylation in Case |
9.02E-01 (Median) | Methylation in Control | 9.05E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A5 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg03021892) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:1.92E-05; Z-score:-1.57E+00 | ||
Methylation in Case |
7.97E-01 (Median) | Methylation in Control | 8.43E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A5 in colorectal cancer | [ 7 ] | |||
Location |
TSS1500 (cg18492059) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:8.56E-04; Z-score:-5.59E-01 | ||
Methylation in Case |
8.76E-01 (Median) | Methylation in Control | 8.94E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A5 in colorectal cancer | [ 7 ] | |||
Location |
TSS200 (cg21197919) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:2.77E-02; Z-score:-2.71E-01 | ||
Methylation in Case |
7.43E-01 (Median) | Methylation in Control | 7.63E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC38A5 in colorectal cancer | [ 7 ] | |||
Location |
Body (cg24455325) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:7.46E-03; Z-score:-6.43E-01 | ||
Methylation in Case |
8.40E-01 (Median) | Methylation in Control | 8.70E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC38A5 in colorectal cancer | [ 7 ] | |||
Location |
3'UTR (cg23948362) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.00E+00 | Statistic Test | p-value:4.40E-02; Z-score:1.60E-02 | ||
Methylation in Case |
8.74E-01 (Median) | Methylation in Control | 8.73E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC38A5 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS200 (cg14014225) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:1.27E-07; Z-score:1.86E+00 | ||
Methylation in Case |
8.21E-01 (Median) | Methylation in Control | 6.16E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC38A5 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg24682551) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.27E+00 | Statistic Test | p-value:5.49E-08; Z-score:-1.08E+00 | ||
Methylation in Case |
2.89E-01 (Median) | Methylation in Control | 3.68E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC38A5 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg24944109) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:9.21E-06; Z-score:7.27E-01 | ||
Methylation in Case |
2.91E-01 (Median) | Methylation in Control | 2.47E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC38A5 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg01992487) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.16E+00 | Statistic Test | p-value:1.10E-03; Z-score:1.14E+00 | ||
Methylation in Case |
4.50E-01 (Median) | Methylation in Control | 3.87E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC38A5 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg10091752) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.12E+00 | Statistic Test | p-value:2.88E-03; Z-score:7.10E-01 | ||
Methylation in Case |
3.81E-01 (Median) | Methylation in Control | 3.41E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC38A5 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg12835313) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:6.42E-03; Z-score:-6.74E-01 | ||
Methylation in Case |
7.26E-01 (Median) | Methylation in Control | 7.62E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC38A5 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg21732977) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:2.30E-02; Z-score:-7.33E-01 | ||
Methylation in Case |
4.45E-02 (Median) | Methylation in Control | 5.29E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Liver cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Moderate/moderate hypomethylation of SLC38A5 in liver cancer than that in healthy individual/adjacent tissue | ||||
Studied Phenotype |
Liver cancer [ICD-11:2C12] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.005929079; Fold-change:-0.267144341; Z-score:-0.850938106 | ||||
The Methylation Level of Disease Section Compare with the Adjacent Tissue |
p-value:9.96E-14; Fold-change:-0.277234234; Z-score:-4.674285843 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue adjacent to the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
DT methylation level in tissue other than the diseased tissue of patients
|
|||||
![]() |
![]() | ||||
Cerebellar liponeurocytoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of SLC38A5 in cerebellar liponeurocytoma than that in healthy individual | ||||
Studied Phenotype |
Cerebellar liponeurocytoma [ICD-11:2A00.0Y] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:0.000199202; Fold-change:-0.347882468; Z-score:-1.963120564 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Significant hypomethylation of SLC38A5 in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value:9.00E-26; Fold-change:-0.449897408; Z-score:-3.516170859 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
![]() |
![]() | ||||
microRNA |
|||||
Unclear Phenotype |
31 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
let-7b directly targets SLC38A5 | [ 9 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Proteomics | ||
miRNA Stemloop ID |
let-7b | miRNA Mature ID | let-7b-5p | ||
miRNA Sequence |
UGAGGUAGUAGGUUGUGUGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon2 |
miR-124 directly targets SLC38A5 | [ 10 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Microarray | ||
miRNA Stemloop ID |
miR-124 | miRNA Mature ID | miR-124-3p | ||
miRNA Sequence |
UAAGGCACGCGGUGAAUGCCAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon3 |
miR-1281 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1281 | miRNA Mature ID | miR-1281 | ||
miRNA Sequence |
UCGCCUCCUCCUCUCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon4 |
miR-155 directly targets SLC38A5 | [ 9 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Proteomics | ||
miRNA Stemloop ID |
miR-155 | miRNA Mature ID | miR-155-5p | ||
miRNA Sequence |
UUAAUGCUAAUCGUGAUAGGGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon5 |
miR-16 directly targets SLC38A5 | [ 9 ] | |||
Epigenetic Type |
microRNA | Experiment Method | pSILAC//Proteomics;Other | ||
miRNA Stemloop ID |
miR-16 | miRNA Mature ID | miR-16-5p | ||
miRNA Sequence |
UAGCAGCACGUAAAUAUUGGCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon6 |
miR-193b directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-193b | miRNA Mature ID | miR-193b-5p | ||
miRNA Sequence |
CGGGGUUUUGAGGGCGAGAUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon7 |
miR-2116 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-2116 | miRNA Mature ID | miR-2116-3p | ||
miRNA Sequence |
CCUCCCAUGCCAAGAACUCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon8 |
miR-30a directly targets SLC38A5 | [ 9 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Proteomics | ||
miRNA Stemloop ID |
miR-30a | miRNA Mature ID | miR-30a-5p | ||
miRNA Sequence |
UGUAAACAUCCUCGACUGGAAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon9 |
miR-3170 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3170 | miRNA Mature ID | miR-3170 | ||
miRNA Sequence |
CUGGGGUUCUGAGACAGACAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon10 |
miR-3176 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3176 | miRNA Mature ID | miR-3176 | ||
miRNA Sequence |
ACUGGCCUGGGACUACCGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon11 |
miR-3661 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3661 | miRNA Mature ID | miR-3661 | ||
miRNA Sequence |
UGACCUGGGACUCGGACAGCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon12 |
miR-3922 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3922 | miRNA Mature ID | miR-3922-3p | ||
miRNA Sequence |
UCUGGCCUUGACUUGACUCUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon13 |
miR-4691 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4691 | miRNA Mature ID | miR-4691-5p | ||
miRNA Sequence |
GUCCUCCAGGCCAUGAGCUGCGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon14 |
miR-4733 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4733 | miRNA Mature ID | miR-4733-3p | ||
miRNA Sequence |
CCACCAGGUCUAGCAUUGGGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon15 |
miR-4757 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4757 | miRNA Mature ID | miR-4757-5p | ||
miRNA Sequence |
AGGCCUCUGUGACGUCACGGUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon16 |
miR-4778 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4778 | miRNA Mature ID | miR-4778-3p | ||
miRNA Sequence |
UCUUCUUCCUUUGCAGAGUUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon17 |
miR-492 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-492 | miRNA Mature ID | miR-492 | ||
miRNA Sequence |
AGGACCUGCGGGACAAGAUUCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon18 |
miR-5193 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5193 | miRNA Mature ID | miR-5193 | ||
miRNA Sequence |
UCCUCCUCUACCUCAUCCCAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon19 |
miR-631 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-631 | miRNA Mature ID | miR-631 | ||
miRNA Sequence |
AGACCUGGCCCAGACCUCAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon20 |
miR-660 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-660 | miRNA Mature ID | miR-660-3p | ||
miRNA Sequence |
ACCUCCUGUGUGCAUGGAUUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon21 |
miR-6744 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6744 | miRNA Mature ID | miR-6744-3p | ||
miRNA Sequence |
GGGCCUCUCUUGUCAUCCUGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon22 |
miR-6749 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6749 | miRNA Mature ID | miR-6749-3p | ||
miRNA Sequence |
CUCCUCCCCUGCCUGGCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon23 |
miR-6791 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6791 | miRNA Mature ID | miR-6791-3p | ||
miRNA Sequence |
UGCCUCCUUGGUCUCCGGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon24 |
miR-6792 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6792 | miRNA Mature ID | miR-6792-3p | ||
miRNA Sequence |
CUCCUCCACAGCCCCUGCUCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon25 |
miR-6829 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6829 | miRNA Mature ID | miR-6829-3p | ||
miRNA Sequence |
UGCCUCCUCCGUGGCCUCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon26 |
miR-6855 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6855 | miRNA Mature ID | miR-6855-5p | ||
miRNA Sequence |
UUGGGGUUUGGGGUGCAGACAUUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon27 |
miR-6875 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6875 | miRNA Mature ID | miR-6875-3p | ||
miRNA Sequence |
AUUCUUCCUGCCCUGGCUCCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon28 |
miR-6878 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6878 | miRNA Mature ID | miR-6878-3p | ||
miRNA Sequence |
CUGGCCUCUUCUUUCUCCUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon29 |
miR-6881 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6881 | miRNA Mature ID | miR-6881-3p | ||
miRNA Sequence |
AUCCUCUUUCGUCCUUCCCACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon30 |
miR-6890 directly targets SLC38A5 | [ 12 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6890 | miRNA Mature ID | miR-6890-5p | ||
miRNA Sequence |
CAUGGGGUAGGGCAGAGUAGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon31 |
miR-877 directly targets SLC38A5 | [ 11 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-877 | miRNA Mature ID | miR-877-3p | ||
miRNA Sequence |
UCCUCUUCUCCCUCCUCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.